Tamar Rudnick is a healthcare executive who has spent 10+ years in leadership roles
across early-stage, public company, and PE-backed businesses. She is currently an
Operating Partner at Define Ventures, one of the largest early-stage digital health VCs
with ~$800M under management and $22B in exited value.
At Define Ventures, Tamar leads strategic growth initiatives. Based in Silicon Valley,
Define invests in early-stage companies from Seed stage to Series B, and has backed
and built some of the category-leading companies such as Livongo, HIMS, and Evolent.
Define differentiates itself by providing unparalleled expertise in go-to-market and
commercialization. Tamar leads this work—developing relationships with a coalition of
industry-leading Payers, Health Systems, and Life Sciences companies. To date, Define
has delivered customer contracts for over 50% of their portfolio companies.
Prior to Define Ventures, Tamar was the SVP of Growth at apree health, where she was
responsible for leading Sales, Enablement, Marketing, and Customer teams across
Employer and Health Plan segments. apree health is a leader in tech-enabled primary
care delivery for commercial organizations, including Fortune 500 Employers and
National Health Plans with Elevance as a key strategic partner. apree health was
formed as a combination of Castlight Health and Vera Whole Health. At apree, Tamar
led the commercial team, delivering 30% revenue growth for the combined business
while integrating two commercial organizations and developing the combined go-to-
market strategy.
What you’ll learn about in this episode:
Additional resources: